Determination of Ellagic Acid Compound Activity as Anti Breast Cancer

摘要

This research was conducted to determine the activity of ellagic acid compounds as anti-breast cancer. The research was carried out through Molecular Docking in silico with several stages such as optimization of the structure of 3D ellagic acid compounds and docking between optimized ellagic acid compounds and NUDT5 protein. Molecular docking is done using the software of Autodock Tools 1.5.6 and Discovery Studio 2016. The results showed that ellagic acid has the potential as an anti-breast cancer compound based on its binding energy to the NUDT5 protein of -3.98 kcal/mol and an inhibitor constant of 1.21 mM.